PGIM Investments has been honored with nine 2025 LSEG Lipper Fund Awards, in recognition of the firm's investment excellence across several funds spanning multiple asset classes. This press release ...
Celebrities always say they’re just like us, now one British actor is putting his money where his mouth is by taking the London Underground. After rising to fame for his roles in Me Before You ...
A tanker subject to the new U.S. sanctions is discharging Russian oil at a port operated by Shandong Port Group in east China, shipping data on LSEG Eikon showed on Thursday.The tanker is the ...
The disability tax credit (DTC) is underused due to complexities in the application process, tax filing difficulties and challenges with CRA processes and contact centres, according to the 2024 annual ...
Risk prevention technology provider LSEG Risk Intelligence has broadened the availability of its Global Account Verification (GAV) service. This solution, initially launched for US customers in ...
Looking for a hint for today’s Connections puzzle? Below, we have clues to help you unlock whichever category has you stumped for the puzzle on March 4, 2025. Connections first launched on the ...
Aptly named Reflect, the pavilion was created by architect Matthew Springett and educator Fiona MacDonald, who work together as Matt+Fiona, with a group of 18 "young placemakers" tasked with ...
An icon of 3 horizontal dots. An icon of a paper envelope. An icon of a facebook f logo. An icon of a digital camera. An icon of a house. An icon of the Instagram logo. An icon of the LinkedIn logo.
London's lack of space and strict planning restrictions are pushing some locals to look underground in their search for a home. Our latest lookbook brings together six sun-catching examples. To ...
Lucid (LCID) CEO Peter Rawlinson is passing the baton just as the EV maker enters a critical growth phase. After over a decade at the helm, Rawlinson said it’s the right time to step aside.
HAYWARD, Calif., February 26, 2025--(BUSINESS WIRE)--Eikon Therapeutics, Inc., a pivotal-stage biotechnology company that integrates advanced engineering with cutting-edge molecular and cell ...
In a report released today, Michael Werner from UBS maintained a Buy rating on London Stock Exchange (LSEG – Research Report), with a price target of £140.00. The company’s shares closed ...